EasyDiagnosis, a public listed company from China, is a leading developer, manufacturer and marketer of In-Vitro Diagnostic (IVD) products, which aims to provide better health for everyone.

Today, EasyDiagnosis's innovative and reliable solutions, especially its IVD products like POCT (Point of Care Testing), are distributed worldwide to more than 50 countries.

EasyDiagnosis offers a comprehensive range of products across four primary business segments which include Blood Gas Analysis, lmmuno Diagnostics, Molecular Diagnostics and Coagulation Analysis.

Since its establishment in 2008, the company has experienced remarkable growth and achieved a sales revenue of USD 1.5 billion in 2022. EasyDiagnosis currently has a global team of 1,500 employees, and its products are utilized by over 7,000 medical facilities located in 5 continents.